<

UCB (EBR:UCB) UCB Media Room: Transparency Notification

Transparency directive : regulatory news

06/07/2018 20:00

Transparency notifications BlackRock, Inc.

  • 2 notifications referring to situation on 29 June and 2 July 2018
  • Threshold crossed: 5%
  • Latest shareholding: 4,91%
Brussels (Belgium), 6 July 2018 – 20:00 (CEST) – regulated information
 
1. Summary of the notifications
Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings, UCB SA/NV announces that it has received 2 transparency notifications both dated 3 July 2018 from BlackRock, Inc. (having its registered office at 55 East 52nd Street, New York, NY, 10055, U.S.A.). 
 
In the first notification BlackRock, Inc. has notified that, following an acquisition of UCB shares with voting rights and equivalent financial instruments by its affiliates, its shareholding in UCB SA has increased and has crossed the 5% threshold on 29 June 2018.
 
In the second notification, BlackRock, Inc. has informed that, following a disposal of UCB shares with voting rights and equivalent financial instruments by its affiliates, its shareholding in UCB SA/NV has decreased and has crossed downward the 5% threshold on 2 July 2018.
 
On 29 June 2018, BlackRock, Inc. (taking into account the holding of its affiliates) owned 9 000 969 UCB shares with voting rights (versus 5 836 096 shares in its previous notification dated 2 June 2017), representing 4.63% of the total number of shares issued by the company (194 505 658) (versus 3.00% in the notification dated 2 June 2017), as well as 790 335 equivalent financial instruments (versus 379 722 in its previous notification dated 2 June 2017) representing 0.41% of the total number of shares issued by the company (versus 0.20% in the notification dated 2 June 2017).
 
On 2 July 2018, BlackRock, Inc. (taking into account the holding of its affiliates) owned 8 780 237 UCB shares with voting rights, representing 4.51% of the total number of shares issued by the company, as well as 779 207 equivalent financial instruments, representing 0.40% of the total number of shares issued by the company.
 
2. Content of the notifications
2.1 The information mentioned hereafter was identical in both notifications:
  • Reason for the notification: Acquisition or disposal of voting securities or voting rights
  • Notification by: A parent undertaking or a controlling person.
  • Persons subject to the notification requirement
  • Threshold crossed (in %): 5%
  • Denominator: 194 505 658 
  • Chain of controlled undertakings through which the holding is effectively held:
Please see the full chain of control in the PDF which is attached to the notifications.
 
2.2. The first transparency notification dated 3 July 2018 included the following specific information:
Date on which the threshold is crossed: 29 June 2018
Notified details:
 
Additional information
The disclosure obligation arose due to voting rights attached to shares for BlackRock, Inc. going above 5%.
 
2.3. The second transparency notification dated 3 July 2018 includes the following specific information:
Date on which the threshold is crossed: 2 July 2018
Notified details:
 
 
Additional information: The disclosure obligation arose due to total holding in voting rights for BlackRock, Inc. going below 5%.
 
3. Further information 
This press release and the detailed transparency notification are available on UCB SA/NV’s website via the following link.
An updated overview of the UCB SA/NV large shareholdings will be available on UCB SA/NV’s website via the following link.
 
Investor Relations
Antje Witte,
Investor Relations, UCB
 
Isabelle Ghellynck,
Investor Relations, UCB
T +32 2 559 94 14, 
antje.witte@ucb.com T +32 2 559 95 88, isabelle.ghellynck@ucb.com
 
About UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases in immunology and neurology. With more than 7 500 people in approximately 40 countries, the company generated revenue of € 4.5 billion in 2017. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twitter: @UCB_news
 
 


If you would rather not receive future communications from UCB SA, let us know by clicking here.
UCB SA, Allée de la Recherche, 60 ., Brussels, . B - 1070 Belgium


Other stories

28/03/2024 16:20
28/03/2024 12:26
28/03/2024 14:06
28/03/2024 16:30
28/03/2024 14:26
28/03/2024 14:43
28/03/2024 15:38
28/03/2024 14:29
28/03/2024 13:13
28/03/2024 11:05
28/03/2024 15:09
28/03/2024 14:24
28/03/2024 09:33
28/03/2024 06:35
28/03/2024 15:34
28/03/2024 16:49
28/03/2024 09:59
28/03/2024 10:07
28/03/2024 14:10
28/03/2024 10:49
27/03/2024 01:33
27/03/2024 17:00
28/03/2024 12:54
28/03/2024 09:01
28/03/2024 14:00
28/03/2024 10:12
28/03/2024 15:52
28/03/2024 13:59
27/03/2024 22:29
28/03/2024 10:02
27/03/2024 23:22
27/03/2024 21:46
27/03/2024 20:21
27/03/2024 20:12
28/03/2024 13:25
28/03/2024 12:57
28/03/2024 12:15
28/03/2024 02:42